Xue Fen, Hu Chaosu, He Xiayun
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Shanghai, China.
J Cancer. 2017 Mar 15;8(6):993-999. doi: 10.7150/jca.17858. eCollection 2017.
To analyze the long-term patterns of regional failure following intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC).
From January 2005 to December 2010, 275 non-metastatic NPC patients treated with IMRT were retrospectively enrolled. Patients staged as II (lymph nodes measuring 4 or more cm in diameter), III or IV also received chemotherapy. Failures were assessed as in-field or out-field relative to the pretreatment planning computed tomography data sets. Univariate and multivariate analyses were performed with Cox proportional hazards model to analyze the effect of various prognostic factors on regional failure-free survival (RFFS) and overall survival (OS).
During a median follow-up of 71 months, the RFFS and OS rates were 94.3% and 83.9%, respectively. Seventeen patients developed regional failures, of which 16 were in-field; one patient showed an out-field failure in the parotid gland, and no recurrences were seen for level Ib. Failures in level II and in the retropharyngeal area accounted for 70.6% (12/17) and 52.9% (9/17) of all failures, respectively. The 5-year RFFS rates for patients with classifications of N0-1 and N2-3 were 98.5% and 90.2%, respectively (p = 0.001). Multivariate analysis showed that N stage was the only independent prognostic predictor of RFFS (HR 7.363, 95% CI 1.516-35.756, p = 0.013).
The regional failure of NPC after treatment with IMRT is uncommon but is significantly higher in N2-3 patients than in N0-1 patients. In-field failures represent the main pattern of regional recurrence and are most often detected in level II and in the retropharyngeal area, while out-field failure is rare. Close attention should be directed to NPC patients with advanced N stages.
分析鼻咽癌(NPC)调强放疗(IMRT)后区域失败的长期模式。
回顾性纳入2005年1月至2010年12月接受IMRT治疗的275例非转移性NPC患者。分期为II期(淋巴结直径4厘米或更大)、III期或IV期的患者也接受了化疗。根据治疗前计划计算机断层扫描数据集评估失败情况为野内或野外。采用Cox比例风险模型进行单因素和多因素分析,以分析各种预后因素对区域无失败生存(RFFS)和总生存(OS)的影响。
中位随访71个月时,RFFS率和OS率分别为94.3%和83.9%。17例患者出现区域失败,其中16例为野内失败;1例患者腮腺出现野外失败,Ib水平未见复发。II水平和咽后区域的失败分别占所有失败的70.6%(12/17)和52.9%(9/17)。N0-1和N2-3分类患者的5年RFFS率分别为98.5%和90.2%(p = 0.001)。多因素分析显示,N分期是RFFS的唯一独立预后预测因素(HR 7.363,95%CI 1.516 - 35.756,p = 0.013)。
IMRT治疗后NPC的区域失败并不常见,但N2-3期患者明显高于N0-1期患者。野内失败是区域复发的主要模式,最常出现在II水平和咽后区域,而野外失败罕见。应密切关注N分期较晚的NPC患者。